| Financial Year |
March 31 2023 |
| Monetary Funds |
1,102,984,351.40 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
26,739,108.81 |
| Advances to Suppliers |
8,371,929.50 |
| Other Receivables |
50,422,552.59 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
749,309.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,539,756.27 |
| Other Current Assets |
13,068,085.44 |
| Total Current Assets |
1,203,875,093.27 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
14,314,455.10 |
| Long-term Equity Investment |
85,420,091.50 |
| Investment Properties |
68,557,967.00 |
| Fixed Assetes |
166,873,515.37 |
| Under-construction Projects |
53,225,490.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
28,268,701.00 |
| R&D expenses |
-- |
| Goodwill |
1,122,179,406.47 |
| Long-Term Deferred and Prepaid Expenses |
226,087,741.06 |
| Deferred Income Tax Assets |
7,004,057.82 |
| Other Non-Current Assets |
9,357,803.61 |
| Sub-Total of Non-Current Assets |
2,169,259,266.11 |
| Total Assets |
3,373,134,359.38 |
| Short-Term Loans |
1,075,668,966.48 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
51,658.71 |
| Accounts Received In Advance |
102,978,273.58 |
| Employee Compensation Payable |
215,834,380.09 |
| Taxes Payable |
70,699,089.67 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
221,007,842.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
114,100,085.75 |
| Other Current Liabilities |
56,097,392.44 |
| Sub-Total of Current Liabilities |
2,666,424,202.38 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
338,849.60 |
| Deferred Income Tax Liabilities |
5,189,383.11 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
279,886,355.57 |
| Total Liabilities |
2,946,310,557.95 |
| Paid-In Capital(Or Share Stock) |
117,762,709.00 |
| Capital Surplus |
859,033,567.21 |
| Surplus Reserve |
4,590,910.24 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-538,556,668.92 |
| Minority Stockholder's Interest |
-12,913,171.05 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
439,736,972.48 |
| Owner's Equity（Stockholder's Equity） |
426,823,801.43 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,373,134,359.38 |
